Post-Transplant Cardiovascular Disease in Kidney Transplant Recipients: Incidence, Risk Factors, and Outcomes in the

Chukwuma Austin Chukwu1,2, Anirudh Rao1,3, Rachel Middleton1,2

  • 1Faculty of Biology, Medicine and Health, Division of Cardiovascular Medicine, The University of Manchester, Manchester M13 9PL, UK.

PubMed

Insights

Post-transplant cardiovascular disease (PTCVD) affects kidney transplant recipients without prior heart issues. While not directly causing graft loss, PTCVD significantly increases recipient mortality, highlighting the need for better monitoring and care.

Area of Science:

  • Nephrology and Transplant Medicine
  • Cardiovascular Research
  • Epidemiology

Background:

  • Post-transplant cardiovascular disease (PTCVD) is a major complication in kidney transplant recipients (KTRs).
  • Understanding PTCVD in KTRs without pre-existing cardiovascular disease (CVD) is crucial for improving outcomes.

Purpose of the Study:

  • To determine the incidence of PTCVD in KTRs without prior CVD.
  • To identify risk factors associated with PTCVD development.
  • To evaluate the impact of PTCVD on graft survival and recipient mortality.

Main Methods:

  • Retrospective analysis of 749 kidney transplant recipients without pre-existing CVD.
  • Competing risk regression to identify PTCVD predictors.
  • Cox proportional hazards analysis to assess PTCVD's impact on graft and recipient survival.

Main Results:

  • Cumulative incidence of PTCVD reached 22.5% by 20 years post-transplant.
  • Independent predictors for PTCVD included older age, longer dialysis duration, and declining estimated glomerular filtration rate (eGFR).
  • PTCVD correlated with increased all-cause graft loss and significantly higher recipient mortality, but not death-censored graft loss.

Conclusions:

  • Age, dialysis duration, and eGFR decline are key predictors of PTCVD in KTRs.
  • PTCVD is a significant risk factor for mortality in kidney transplant recipients.
  • Enhanced clinical management and surveillance are necessary for KTRs at risk of PTCVD.